Publication | Closed Access

A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo

Medicinal ChemistryDoxorubicin Anticancer ActivityAnticancer AgentMedicinePharmacological AgentPharmacotherapyAnti-cancer AgentNormal CellsPharmacologyRadiation OncologyDrug Discovery